| Current research therapeutic strategies for Alzheimer’s disease treatment J Folch, D Petrov, M Ettcheto, S Abad, E Sánchez-López, ML García, ... Neural plasticity 2016, 2016 | 326 | 2016 |
| Memantine for the treatment of dementia: a review on its current and future applications J Folch, O Busquets, M Ettcheto, E Sánchez-López, RD Castro-Torres, ... Journal of Alzheimer's Disease 62 (3), 1223-1240, 2018 | 235 | 2018 |
| Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model A Cano, M Ettcheto, JH Chang, E Barroso, M Espina, BA Kühne, ... Journal of Controlled Release 301, 62-75, 2019 | 234 | 2019 |
| Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease I Pedrós, D Petrov, M Allgaier, F Sureda, E Barroso, C Beas-Zarate, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014 | 201 | 2014 |
| High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents D Petrov, I Pedrós, G Artiach, FX Sureda, E Barroso, M Pallàs, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (9 …, 2015 | 168 | 2015 |
| Involvement of calpain activation in neurodegenerative processes A Camins, E Verdaguer, J Folch, M Pallàs CNS drug reviews 12 (2), 135-148, 2006 | 168 | 2006 |
| Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death J Folch, F Junyent, E Verdaguer, C Auladell, JG Pizarro, C Beas-Zarate, ... Neurotoxicity research 22, 195-207, 2012 | 160 | 2012 |
| The role of CDK5/P25 formation/inhibition in neurodegeneration. A Camins, E Verdaguer, J Folch, AM Canudas, M Pallàs Drug news & perspectives 19 (8), 453-460, 2006 | 156 | 2006 |
| Review of the advances in treatment for Alzheimer disease: strategies for combating β-amyloid protein J Folch, M Ettcheto, D Petrov, S Abad, I Pedrós, M Marin, J Olloquequi, ... Neurología (English Edition) 33 (1), 47-58, 2018 | 145 | 2018 |
| Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women M Bulló, MR Peeraully, P Trayhurn, J Folch, J Salas-Salvadó European Journal of Endocrinology 157 (3), 303-310, 2007 | 145 | 2007 |
| Modulation of SIRT1 expression in different neurodegenerative models and human pathologies M Pallas, JG Pizarro, J Gutierrez-Cuesta, N Crespo-Biel, D Alvira, M Tajes, ... Neuroscience 154 (4), 1388-1397, 2008 | 130 | 2008 |
| Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons D Alvira, M Yeste-Velasco, J Folch, E Verdaguer, AM Canudas, M Pallas, ... Neuroscience 147 (3), 746-756, 2007 | 115 | 2007 |
| Long-term exposition to a high fat diet favors the appearance of β-amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer’s disease O Busquets, M Ettcheto, M Pallàs, C Beas-Zarate, E Verdaguer, ... Mechanisms of ageing and development 162, 38-45, 2017 | 101 | 2017 |
| Sirtuin activators: designing molecules to extend life span A Camins, FX Sureda, F Junyent, E Verdaguer, J Folch, C Pelegri, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799 (10-12 …, 2010 | 97 | 2010 |
| Understanding the role of hypoxia inducible factor during neurodegeneration for new therapeutics opportunities A Merelli, JCG Rodríguez, J Folch, MR Regueiro, A Camins, A Lazarowski Current Neuropharmacology 16 (10), 1484-1498, 2018 | 94 | 2018 |
| Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease D Alvira, M Tajes, E Verdaguer, D Acuña‐Castroviejo, J Folch, A Camins, ... Journal of pineal research 40 (3), 251-258, 2006 | 91 | 2006 |
| Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease D Alvira, M Tajes, E Verdaguer, D Acuña‐Castroviejo, J Folch, A Camins, ... Journal of pineal research 40 (3), 251-258, 2006 | 91 | 2006 |
| Masitinib for the treatment of mild to moderate Alzheimer’s disease J Folch, D Petrov, M Ettcheto, I Pedros, S Abad, C Beas-Zarate, ... Expert review of neurotherapeutics 15 (6), 587-596, 2015 | 82 | 2015 |
| Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy A Cano, M Ettcheto, M Espina, C Auladell, AC Calpena, J Folch, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (4), 1073-1085, 2018 | 78 | 2018 |
| New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9 E Sánchez-López, M Ettcheto, MA Egea, M Espina, AC Calpena, J Folch, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 1171-1182, 2017 | 73 | 2017 |
Francesc X. SuredaProfessor Titular, Unitat de farmacologia, Universitat Rovira i VirgiliVerified email at urv.cat
